Dexmedetomidine Use in a Case of Severe Cancer Pain

References

• National Comprehensive Cancer Network. Adult cancer pain (Version 2.2019) March 15, 2019. [accessed 2019 Apr 15]. https://www.nccn.org/professionals/physician_gls/pdf/pain.pdf.
   Google Scholar
• McNicol E, Horowicz-Mehler N, Fisk RA, Bennett K, Gialeli-Goudas M, Chew PW, Lau J, Carr D; Americal Pain Society. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain. 2003;4(5):231–56. doi: 10.1016/S1526-5900(03)00556-X.
   PubMed Web of Science ®Google Scholar
• Morgan MM, Christie MJ. Analysis of opioid efficacy, tolerance, addiction, and dependence from cell culture to human. Br J Pharmacol. 2011;164(4):1322–34. doi: 10.1111/j.1476-5381.2011.01335.x.
   PubMed Web of Science ®Google Scholar
• Fine PG, Portenoy RK; Ad Hoc Expert Panel on Evidence Review and Guidelines for Opioid Rotation. Establishing “best practices” for opioid rotation: conclusions of an expert panel. J Pain Symptom Manage. 2009;38(3):418–25. doi: 10.1016/j.jpainsymman.2009.06.002.
   PubMed Web of Science ®Google Scholar
• Müller-Busch HC, Lindena G, Tietze K, Woskanjan S. Opioid switch in palliative care, opioid choice by clinical need and opioid availability. Eur J Pain. 2005;9(5):571–9. doi: 10.1016/j.ejpain.2004.12.003.
   PubMed Web of Science ®Google Scholar
• Gilbar PJ, Ridge AM. Inappropriate labelling of patients as opioid allergic. J Oncol Pharm Pract. 2004;10(3):177–82. doi: 10.1191/1078155204jp132oa.
   Google Scholar
• Li PH, Ue KL, Wagner A, Kutkowski R, Rutkowski K. Opioid hypersensitivity: predictors of allergy and role of drug provocation testing. J Allergy Clin Immunol Pract. 2017;5(6):1601–6. doi: 10.1016/j.jaip.2017.03.035.
   PubMed Web of Science ®Google Scholar
• Bruera E. Parenteral opioid shortage–treating pain during the opioid-overdose epidemic. N Engl J Med. 2018;379(7):601–3. doi: 10.1056/NEJMp1807117.
   PubMed Web of Science ®Google Scholar
• Hollingsworth H, Herndon C. The parenteral opioid shortage: causes and solutions. J Opioid Manag. 2018;14(2):81–2. doi: 10.5055/jom.2018.0434.
   PubMedGoogle Scholar
• Loveday BA, Sindt J. Ketamine protocol for palliative care in cancer patients with refractory pain. J Adv Pract Oncol. 2015;6(6):555–61.
   PubMedGoogle Scholar
• Schwenk ES, Viscusi ER, Buvanendran A, Hurley RW, Wasan AD, Narouze S. Consensus guidelines on the use of intravenous ketamine infusions for acute pain management from the American society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Reg Anesth Pain Med. 2018;43(5):456–66. doi: 10.1097/AAP.0000000000000806.
   PubMed Web of Science ®Google Scholar
• Kandil E, Melikman E, Adinoff B. Lidocaine infusion: a promising therapeutic approach for chronic pain. J Anesth Clin Res. 2017;8(1):697. doi: 10.4172/2155-6148.1000697.
   PubMedGoogle Scholar
• Precedex (dexmedetomidine)for Injection [package insert on Internet]. Lake Forest (IL): Hospira; 1999 [revised 2013 June]. [accessed 2018 May 21]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021038s021lbl.pdf.
   Google Scholar
• Sadhasivam S, Boat A, Mahmoud M. Comparison of patient-controlled analgesia with and without dexmedetomidine following spine surgery in children. J Clin Anesth. 2009;21(7):493–501. doi: 10.1016/j.jclinane.2008.12.017.
   PubMed Web of Science ®Google Scholar
• Barletta JF, Miedema SL, Wiseman D, Heiser JC, McAllen KJ. Impact of dexmedetomidine on analgesic requirements in patients after cardiac surgery in a fast-track recovery room setting. Pharmacotherapy. 2009;29(12):1427–32. doi: 10.1592/phco.29.12.1427.
   PubMed Web of Science ®Google Scholar
• Wallace S, Mecklenburg B, Hanling S. Profound reduction in sedation and analgesic requirements using extended dexmedetomidine infusions in a patient with an open abdomen. Mil Med. 2009;174(11):1228–30. doi: 10.7205/MILMED-D-00-6009.
   PubMed Web of Science ®Google Scholar
• Gerlach AT, Dasta JF. Dexmedetomidine: an updated review [published correction appears in Ann Pharmacother. 2007;41(3):530–1]. Ann Pharmacother. 2007;41(2):245–52. doi: 10.1345/aph.1H314.
   PubMed Web of Science ®Google Scholar
• Murray A, Hagen NA. Hydromorphone. J Pain Symptom Manage. 2005;29(5 Suppl):S57–S66. doi: 10.1016/j.jpainsymman.2005.01.007.
   PubMed Web of Science ®Google Scholar
• Jonkman K, van de Donk T, Dahan A. Ketamine for cancer pain: what is the evidence? Curr Opin Support Palliat Care. 2017;11(2):88–92. doi: 10.1097/SPC.0000000000000262.
   PubMed Web of Science ®Google Scholar
• Roberts SB, Wozencraft CP, Coyne PJ, Smith TJ. Dexmedetomidine as an adjuvant analgesic for intractable cancer pain. J Palliat Med. 2011;14(3):371–3. doi: 10.1089/jpm.2010.0235.
   PubMed Web of Science ®Google Scholar
• Coyne PJ, Wozencraft CP, Roberts SB, Bobb B, Smith TJ. Dexmedetomidine: exploring its potential role and dosing guideline for its use in intractable pain in the palliative care setting. J Pain Palliat Care Pharmacother. 2010;24(4):384–6. doi: 10.3109/15360288.2010.518227.
   PubMedGoogle Scholar
• O’Hara C, Tamburro RF, Ceneviva GD. Dexmedetomidine for sedation during withdrawal of support. Palliat Care. 2015;9:15–8. doi: 10.4137/PCRT.S27954.
   PubMedGoogle Scholar
• IBM Micromedex®. Alternative Medicine (electronic version). IBM Watson Health, Greenwood Village, Colorado, USA. 2019. [Accessed 2019 Apr 15]. https://www-micromedexsolutions-com.ezproxy.samford.edu/.
   Google Scholar
• Srivastava U, Sarkar ME, Kumar A, Gupta A, Agarwal A, Singh TK, Badada V, Dwivedi Y. Comparison of clonidine and dexmedetomidine for short-term sedation of intensive care unit patients. Indian J Crit Care Med. 2014;18(7):431–6. doi: 10.4103/0972-5229.136071.
   PubMedGoogle Scholar
• Allen TK, Mishriky BM, Klinger RY, Habib AS. The mpact of neuraxial clonidine on postoperative analgesia and perioperative adverse effects in women having elective Caesarean section–a systematic review and meta-analysis. Br J Anaesth. 2018;120(2):228–40. doi: 10.1016/j.bja.2017.11.085.
   PubMed Web of Science ®Google Scholar
• Gerlach AT, Murphy CV, Dasta JF. An updated focused review of dexmedetomidine in adults. Ann Pharmacother. 2009;43(12):2064–74. doi: 10.1345/aph.1M310.
   PubMed Web of Science ®Google Scholar
• Guinter JR, Kristeller JL. Prolonged infusions of dexmedetomidine in critically ill patients. Am J Health Syst Pharm. 2010;67(15):1246–53. doi: 10.2146/ajhp090300.
   PubMed Web of Science ®Google Scholar
• Kansal A, Hughes J. Visceral pain. Anaesth Intensive Care Med. 2016;17(11):543–7. doi: 10.1016/j.mpaic.2016.08.013.
   Web of Science ®Google Scholar
• Tompkins DA, Campbell CM. Opioid-induced hyperalgesia: clinically relevant or extraneous research phenomenon? Curr Pain Headache Rep. 2011;15(2):129–36. doi: 10.1007/s11916-010-0171-1.
   PubMed Web of Science ®Google Scholar
• Buscher HCJL, Wilder-Smith OHG, van Goor H. Chronic pancreatitis patients show hyperalgesia of central origin: a pilot study. Eur J Pain. 2006;10(4):363–70. doi: 10.1016/j.ejpain.2005.06.006.
   PubMed Web of Science ®Google Scholar
• Vera-Portocarrero L, Westlund KN. Role of neurogenic inflammation in pancreatitis and pancreatic pain. Neurosignals. 2005;14(4):158–65. doi: 10.1159/000087654.
   PubMedGoogle Scholar
• Krashin D, Murinova N, Jumelle P, Ballantyne J. Opioid risk assessment in palliative medicine. Expert Opin Drug Saf. 2015;14(7):1023–33. doi: 10.1517/14740338.2015.1041915.
   PubMed Web of Science ®Google Scholar